In one aspect, the invention relates to 0-benzyl nicotinamide analogs, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5);synthetic methods for making the compounds;pharmaceutical compositions comprising the compounds;and methods of treating neurological and psychiatric disorders associated with glutamate dysfunction using the compounds and compositions.